Rare diseases
Investigational molecules
Locations
Study on Ruxolitinib and Methoxsalen for Patients with Steroid-Refractory Chronic Graft-versus-Host Disease
GermanyLong-Term Safety and Efficacy Study of Mexiletine Hydrochloride for Patients with Myotonic Dystrophy Type 1 and Type 2
GermanyStudy on VE303 for Preventing Recurrent C. difficile Infection in Patients
GermanyStudy of Avapritinib for Adults with Systemic Mastocytosis Who Previously Participated in an Avapritinib Study
GermanyStudy of Cemiplimab, Carboplatin, and Paclitaxel for Adults with Operable Non-Small Cell Lung Cancer
GermanyStudy of dexpanthenol mouth rinse for preventing radiation-induced oral mucositis in patients receiving radiotherapy
GermanyStudy of Ruxolitinib and Venetoclax for Children with Relapsed or Refractory Leukemia or Lymphoma with IL-7R/JAK-STAT Pathway Mutations
GermanyStudy of Brigatinib for Children and Young Adults with ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors, or Other Solid Tumors
GermanyStudy on Reducing Inflammation in Acute Ischemic Stroke Patients Using Dornase Alfa and Sodium Chloride
GermanySafety Study of Regulatory T Cells (TREG02) in Patients After Kidney Transplant
GermanyStudy on Atezolizumab and Bevacizumab for Patients with Intermediate-Stage Liver Cancer
GermanyStudy Comparing Rituximab and KYV-101 for Patients with Active, ACPA-Positive, Treatment-Resistant Rheumatoid Arthritis
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
